Concepedia

Shunfang Liu

SL

Statistics

Publications

13

Citations

320

H-Index

13

Active since

2011

Affiliations

Tongji Hospital(Current)

Huazhong University of Science and Technology

College of Marin

China Pharmaceutical University

The First People’s Hospital of Lianyungang

Shunfang Liu is an author at Tongji Hospital specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2011–2024

13

Publications

13

Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling

Miao He, Huan Yang, Hangchuan Shi et al. · Cancer Letters · 2021 · 51 citations · Full text

, , +16

Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency

Lin Yang, Guanghai Yang, Yingjun Ding et al. · Oncology Reports · 2018 · 45 citations · Full text

, , +13

MiR-422a weakened breast cancer stem cells properties by targeting <i>PLP2</i>

Yanmei Zou, Chen Yuandong, Shuo Yao et al. · Cancer Biology & Therapy · 2018 · 37 citations · Full text

, , +17

Lentivirus-Mediated Nox4 shRNA Invasion and Angiogenesis and Enhances Radiosensitivity in Human Glioblastoma

Na Han, Tiejun Yin, Lulu Huang et al. · Oxidative Medicine and Cellular Longevity · 2014 · 34 citations · Full text

, , +17

Increased DJ-1 and its prognostic significance in hepatocellular carcinoma.

Shunfang Liu, Zhifang Yang, Honglan Wei et al. · PubMed · 2011 · 30 citations

, , +17

1–5 of 13